Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
POTE ankyrin domain family member B (POTEB) belongs to a family of closely related genes with expression predominantly in reproductive tissues such as prostate, ovary, testis, and placenta. POTEB is a protein-coding gene characterized by multiple ankyrin repeat domains, which are typically involved in mediating protein–protein interactions. Its selective expression in reproductive tissues, and increased expression in some prostate cancers, points to a functional role in reproductive organ physiology and possibly in tumorigenesis. Due to its restricted normal tissue distribution and presence in some cancer types, POTEB and its family members have been proposed as potential diagnostic markers or immunotherapy targets, especially for prostate cancer. However, its precise molecular functions, interacting proteins, and mechanisms are incompletely characterized. POTEB is not considered a classical therapeutic target (such as a receptor or enzyme), and no drugs are currently known to specifically interact with it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on POTE ankyrin domain family member B (POTEB).